Was the Budget Deliberation Sufficient? Asking Ruling and Opposition Party Diet Members: Examining the Contents of the 122 Trillion Yen Budget, with “Medical Fee Revision” as a Focus Area – Niigata News NST

News Highlights

Regarding the deliberation of the FY2026 budget proposal, based on interviews with ruling and opposition party Diet members, the massive budget of 122 trillion yen and its contents are discussed, with “medical fee revision” highlighted as a particularly noteworthy item. This revision is a crucial factor directly impacting the management of medical institutions, making the formulation of mid-to-long-term management strategies and business succession plans essential. Furthermore, utilizing tax schemes such as maintaining facility standards through economies of scale, dispersing the burden of capital investment, and transitioning to specific medical corporations or social medical corporations are also suggested from the perspective of strengthening management.

M&A Medical Editorial Department’s Perspective

The attention on medical fee revisions in the FY2026 budget proposal presents an urgent management challenge for healthcare providers. The fact that medical fee revisions were highlighted as a “focus area” within the discussion of the 122 trillion yen national budget suggests a significant shift towards restructuring the healthcare delivery system, extending beyond mere policy changes. In particular, for medical institutions struggling with a lack of successors, the urgent need to rebuild mid-to-long-term management strategies that consider the revision cycle, and business succession strategies, is paramount. The economies of scale achieved through group formation can not only reduce costs but also lead to maintaining facility standards and dispersing the burden of high capital investment, serving as an effective option for ensuring the continuity of regional healthcare. Moreover, utilizing tax schemes with a view to transitioning to specific medical corporations or social medical corporations is an indispensable element for building a sustainable management foundation. This budget deliberation presents a heightened need to re-examine one’s own management and succession strategies.

Points Raised by This News

• The positioning of medical fee revisions as a “focus area” within the 122 trillion yen budget underscores their significant impact on healthcare management.
• The formulation of mid-to-long-term management and succession strategies, considering the revision cycle, is directly linked to the survival of individual medical institutions.
• Economies of scale through group formation contribute to ensuring the continuity of regional healthcare by maintaining facility standards and dispersing capital investment burdens.
• The utilization of tax schemes involving transitions to specific medical corporations or social medical corporations is an important option for strengthening the management base.

Practical Questions Arising from This News

• When and how are the specific details of medical fee revisions decided?
• What are the advantages and disadvantages of group formation and changes in corporate status?
• What is the optimal business succession and management strategy, considering a facility’s scale and regional characteristics?

If You Feel “Should I Consult Too?”

In light of the attention given to medical fee revisions during this budget deliberation, individuals who feel vague anxiety about their institution’s management strategy or successor issues should consider consulting with an expert at this time. Particularly when considering maintaining facility standards, future capital investments, and smooth business succession, it is essential to explore optimal schemes (such as changes in corporate status or group formation) tailored to individual circumstances. By grasping the current situation early and taking concrete measures, you can broaden your future options.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, providing support for the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are handled with strict confidentiality. Free consultations are available here.